Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Jan;55(1):34–39. doi: 10.1136/ard.55.1.34

Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis.

K Eberhardt 1, E Fex 1, U Johnson 1, F A Wollheim 1
PMCID: PMC1010079  PMID: 8572731

Abstract

OBJECTIVE--To evaluate the clinical usefulness of genomic HLA typing during the first five years of established rheumatoid arthritis (RA). METHODS--The HLA-DRB and -DQB alleles were determined by restriction length polymorphisms and polymerase chain reaction amplification with sequence specific primers in 99 Swedish patients with RA. Clinical features after two and five years disease duration were related to the genetic pattern. Seventy four patients were seropositive, 25 had nodules, 90 developed erosions, and 15 required joint replacements. Twelve patients were in remission after five years. Disability was assessed by health assessment questionnaire, and radiographic damage in hands and feet by the Larsen method. RESULTS--Eighty seven per cent of the patients carried the conserved third hypervariable region sequence (HVR3), 32% had DRB1*04 on one allele, and 26% had DRB1*04 on both alleles (all frequencies significantly greater than in controls). Frequencies of DRB1*04 associated DQB*0301 and *0302 were normal. Patients carrying DRB1*04 on both alleles tended to have more radiographic changes after two years, but this difference had diminished after five years. Disability did not vary with regard to the genotype. Homozygous HVR3 patients had about three times greater risk of undergoing joint replacement. Homozygosity for HVR3 and presence of DQB*0302 both tended to be associated with erosive disease. CONCLUSIONS--We confirmed a strong association of disease with the presence of the shared epitope on one or two alleles. However, genotype was not strongly associated with disease severity after two and five years disease duration, and thus the value of genomic typing to select patients for early aggressive therapy is questionable.

Full text

PDF
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook A., Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977 Feb;36(1):71–73. doi: 10.1136/ard.36.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clarkson R., Bate A. S., Grennan D. M., Chattopadhyay C., Sanders P., Davis M., Kelly C. DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome. Ann Rheum Dis. 1990 Dec;49(12):976–979. doi: 10.1136/ard.49.12.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  4. Eberhardt K. B., Rydgren L. C., Pettersson H., Wollheim F. A. Early rheumatoid arthritis--onset, course, and outcome over 2 years. Rheumatol Int. 1990;10(4):135–142. doi: 10.1007/BF02274837. [DOI] [PubMed] [Google Scholar]
  5. Eberhardt K., Fex E., Johnsson K., Geborek P. Hip involvement in early rheumatoid arthritis. Ann Rheum Dis. 1995 Jan;54(1):45–48. doi: 10.1136/ard.54.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eberhardt K., Grubb R., Johnson U., Pettersson H. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression. J Rheumatol. 1993 Nov;20(11):1825–1829. [PubMed] [Google Scholar]
  7. Eberhardt K., Larsson B. M., Nived K. Early rheumatoid arthritis--some social, economical, and psychological aspects. Scand J Rheumatol. 1993;22(3):119–123. doi: 10.3109/03009749309099255. [DOI] [PubMed] [Google Scholar]
  8. Ekdahl C., Eberhardt K., Andersson S. I., Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17(4):263–271. doi: 10.3109/03009748809098795. [DOI] [PubMed] [Google Scholar]
  9. Gough A., Faint J., Salmon M., Hassell A., Wordsworth P., Pilling D., Birley A., Emery P. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum. 1994 Aug;37(8):1166–1170. doi: 10.1002/art.1780370809. [DOI] [PubMed] [Google Scholar]
  10. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  11. Gustafsson K., Wiman K., Emmoth E., Larhammar D., Böhme J., Hyldig-Nielsen J. J., Ronne H., Peterson P. A., Rask L. Mutations and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J. 1984 Jul;3(7):1655–1661. doi: 10.1002/j.1460-2075.1984.tb02026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heikkilä S., Isomäki H. Long-term outcome of rheumatoid arthritis has improved. Scand J Rheumatol. 1994;23(1):13–15. doi: 10.3109/03009749409102128. [DOI] [PubMed] [Google Scholar]
  13. Kazis L. E., Anderson J. J., Meenan R. F. Health status as a predictor of mortality in rheumatoid arthritis: a five-year study. J Rheumatol. 1990 May;17(5):609–613. [PubMed] [Google Scholar]
  14. Lanchbury J. S., Jaeger E. E., Sansom D. M., Hall M. A., Wordsworth P., Stedeford J., Bell J. I., Panayi G. S. Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Hum Immunol. 1991 Sep;32(1):56–64. doi: 10.1016/0198-8859(91)90117-r. [DOI] [PubMed] [Google Scholar]
  15. Larhammar D., Schenning L., Gustafsson K., Wiman K., Claesson L., Rask L., Peterson P. A. Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3687–3691. doi: 10.1073/pnas.79.12.3687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MacGregor A. J., Silman A. J. Epidemiological approaches to the immunogenetics of autoimmune rheumatic disease. Ann Rheum Dis. 1993 Apr;52(4):310–313. doi: 10.1136/ard.52.4.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McMahon M. J., Hillarby M. C., Clarkson R. W., Hollis S., Grennan D. M. Major histocompatibility complex variants and articular disease severity in rheumatoid arthritis. Br J Rheumatol. 1993 Oct;32(10):899–902. doi: 10.1093/rheumatology/32.10.899. [DOI] [PubMed] [Google Scholar]
  18. Möttönen T. T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis. 1988 Aug;47(8):648–653. doi: 10.1136/ard.47.8.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Olerup O., Aldener A., Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993 Mar;41(3):119–134. doi: 10.1111/j.1399-0039.1993.tb01991.x. [DOI] [PubMed] [Google Scholar]
  20. Olerup O., Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens. 1991 May;37(5):197–204. doi: 10.1111/j.1399-0039.1991.tb01872.x. [DOI] [PubMed] [Google Scholar]
  21. Olsen N. J., Callahan L. F., Brooks R. H., Nance E. P., Kaye J. J., Stastny P., Pincus T. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med. 1988 Feb;84(2):257–264. doi: 10.1016/0002-9343(88)90422-6. [DOI] [PubMed] [Google Scholar]
  22. Paimela L., Leirisalo-Repo M., Helve T., Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol. 1993;22(5):220–224. doi: 10.3109/03009749309095126. [DOI] [PubMed] [Google Scholar]
  23. Pile K., Gibson K., Jessop J., Camilleri J., Emberton R., Wordsworth P. HLA-DR4 subtyping by single-strand polymorphism analysis. Lancet. 1993 Jul 31;342(8866):300–301. doi: 10.1016/0140-6736(93)91844-c. [DOI] [PubMed] [Google Scholar]
  24. Pinals R. S., Masi A. T., Larsen R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981 Oct;24(10):1308–1315. doi: 10.1002/art.1780241012. [DOI] [PubMed] [Google Scholar]
  25. Pincus T., Callahan L. F. Rheumatology function tests: grip strength, walking time, button test and questionnaires document and predict longterm morbidity and mortality in rheumatoid arthritis. J Rheumatol. 1992 Jul;19(7):1051–1057. [PubMed] [Google Scholar]
  26. Pincus T., Callahan L. F., Sale W. G., Brooks A. L., Payne L. E., Vaughn W. K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984 Aug;27(8):864–872. doi: 10.1002/art.1780270805. [DOI] [PubMed] [Google Scholar]
  27. Plant M. J., Saklatvala J., Borg A. A., Jones P. W., Dawes P. T. Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol. 1994 Oct;21(10):1808–1813. [PubMed] [Google Scholar]
  28. Salmon M., Wordsworth P., Emery P., Tunn E., Bacon P. A., Bell J. I. The association of HLA DR beta alleles with self-limiting and persistent forms of early symmetrical polyarthritis. Br J Rheumatol. 1993 Jul;32(7):628–630. doi: 10.1093/rheumatology/32.7.628. [DOI] [PubMed] [Google Scholar]
  29. Sansom D. M., Amin S. N., Bidwell J. L., Klouda P. T., Bradley B. A., Evison G., Goulding N. J., Hall N. D., Maddison P. J. HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: evidence for a link with disease expression. Br J Rheumatol. 1989 Oct;28(5):374–378. doi: 10.1093/rheumatology/28.5.374. [DOI] [PubMed] [Google Scholar]
  30. Singal D. P., Green D., Reid B., Gladman D. D., Buchanan W. W. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis. 1992 Jan;51(1):23–28. doi: 10.1136/ard.51.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stastny P., Ball E. J., Khan M. A., Olsen N. J., Pincus T., Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol. 1988;27 (Suppl 2):132–138. doi: 10.1093/rheumatology/xxvii.suppl_2.132. [DOI] [PubMed] [Google Scholar]
  32. Truedsson L., Sjöholm A. G., Sturfelt G. Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives. Clin Exp Rheumatol. 1985 Jan-Mar;3(1):29–37. [PubMed] [Google Scholar]
  33. Vandenbroucke J. P., Hazevoet H. M., Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol. 1984 Apr;11(2):158–161. [PubMed] [Google Scholar]
  34. Weyand C. M., Hicok K. C., Conn D. L., Goronzy J. J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med. 1992 Nov 15;117(10):801–806. doi: 10.7326/0003-4819-117-10-801. [DOI] [PubMed] [Google Scholar]
  35. Weyand C. M., Xie C., Goronzy J. J. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest. 1992 Jun;89(6):2033–2039. doi: 10.1172/JCI115814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wollheim F. A., Pettersson H., Saxne T., Sjöblom K. G. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis. Scand J Rheumatol. 1988;17(6):445–453. doi: 10.3109/03009748809098805. [DOI] [PubMed] [Google Scholar]
  37. Wordsworth B. P., Lanchbury J. S., Sakkas L. I., Welsh K. I., Panayi G. S., Bell J. I. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10049–10053. doi: 10.1073/pnas.86.24.10049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wordsworth B. P., Stedeford J., Rosenberg W. M., Bell J. I. Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive associations with HLA-DR4, DR1 and DRw10. Br J Rheumatol. 1991 Jun;30(3):178–180. doi: 10.1093/rheumatology/30.3.178. [DOI] [PubMed] [Google Scholar]
  39. Young A., Corbett M., Winfield J., Jaqueremada D., Williams P., Papasavvas G., Hay F., Roitt I. A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis. Br J Rheumatol. 1988 Apr;27(2):94–101. doi: 10.1093/rheumatology/27.2.94. [DOI] [PubMed] [Google Scholar]
  40. Zetterquist H., Olerup O. Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol. 1992 May;34(1):64–74. doi: 10.1016/0198-8859(92)90086-3. [DOI] [PubMed] [Google Scholar]
  41. van Zeben D., Hazes J. M., Zwinderman A. H., Cats A., Schreuder G. M., D'Amaro J., Breedveld F. C. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum. 1991 Jul;34(7):822–830. doi: 10.1002/art.1780340707. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES